黄璐琦，中国工程院院士。北京大学医学部博士，现任中国中医科学院常务副院长、首席研究员，中药资源中心主任，全国中药资源普查试点工作专家指导组组长，科技部重点领域中药资源创新团队负责人，部局共建道地药材国家重点实验室（培育基地）负责人，曾任国家973计划项目首席科学家。组织实施第四次全国中药资源普查试点工作，提出和发展了“分子生药学”和道地药材形成的理论，建立了珍稀濒危常用中药资源五种保护模式。获国家科学技术进步二等奖4项（第一完成人3项，第二完成人1项）。获国家****科学基金资助、全国优秀博士学位论文指导教师等荣誉。

研究方向：中药资源学，分子生药学

代表性论文：
（1）Zhou, YJJ; Gao, W; Rong, QX; Jin, GJ; Chu, HY; Liu, WJ; Yang, W; Zhu, ZW; Li, GH; Zhu, GF; Huang, LQ*; Zhao, ZBK. 2012. Modular Pathway Engineering of Diterpenoid Synthases and the Mevalonic Acid Pathway for Miltiradiene Production. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 134(6): 3234-3241.
（2）Guo, J; Zhou, YJJ; Hillwigc, ML; Shen, Y; Yang, L; Wang, YJ; Zhang, XA; Liu, WJ; Peters, RJ; Chen, XY; Zhao, ZBK; Huang, LQ*. 2013. CYP76AH1 catalyzes turnover of miltiradiene in tanshinones biosynthesis and enables heterologous production of ferruginol in yeasts. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(29): 12108-12113.
（3）Dai, ZB; Liu, Y; Zhang, XA; Shi, MY; Wang, BB; Wang, D; Huang, LQ*; Zhang, XL. 2013. Metabolic engineering of Saccharomyces cerevisiae for production of ginsenosides. METABOLIC ENGINEERING, 20: 146-156.
（4）Guo, J; Ma, XH; Cai, Y; Ma, Y; Zhan, ZL; Zhou, YJ; Liu, WJ; Guan, MX; Yang,J; Cui, GH; Kang, LP; Yang, Lei; Shen, Y; Tang, JF; Lin, HX; Jin, BL; Liu, ZM; Peters, R; Zhao, ZB; Huang, LQ* .2015. Cytochrome P450 promiscuity leads to a bifurcating biosynthetic pathway for tanshinones. NEW PHYTOLOGIST, 210(2): 525-534.
（5）Yuan, QJ; Zhang, B; Jiang, D;Zhang, WJ; Lin, TY; Wang, NH; Chiou, SJ; Huang, LQ*. 2015.Identification of species and materia medica within Angelica L. (Umbelliferae) based on phylogeny inferred from DNA barcodes. MOLECULAR ECOLOGY RESOURCES, 15:358-371.

E-mail：huangluqi01@126.com